Arrhythmia Detection After MI (NCT05073419) | Clinical Trial Compass
RecruitingNot Applicable
Arrhythmia Detection After MI
United States200 participantsStarted 2022-08-09
Plain-language summary
Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults, age 18 years or older
* AMI (STEMI and NSTEMI)
* Willing to give written informed consent
* Expected discharge from hospital within 7 days of AMI
* Willing to receive ICM insertion within 21 days of index AMI
Exclusion Criteria:
* Existing pacemaker, ICD, ICM, or any other implantable cardiac electronic device
* Pregnant
* Index AMI was more than 21 days
* Unwilling/cannot insert ICM within 21 days post AMI
* Planned ICD implant, planned CABG or any open-heart surgery (e.g. for severe valvular disease)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is focused on detecting cardiac arrhythmias after a heart attack — how would joining this study change how closely my heart rhythm is monitored compared to my usual care after a myocardial infarction?
2The trial is measuring 'time to diagnosis and treatment' of arrhythmias — can you explain what that means in practice for me, and whether faster arrhythmia detection might make a real difference in my specific situation?
3Since this trial doesn't have a traditional phase number, which usually means it's more about testing a process or device than a new drug, can you help me understand what I'd actually be asked to do or wear as part of this study?
4One of the things this trial tracks is 'changes to patient management' — does that mean my treatment plan could be altered based on what the monitoring finds, and how would that be handled if something concerning shows up?
5Given that I've just had a heart attack, would you recommend I consider this monitoring trial alongside my standard recovery care, or are there reasons my current condition might make it a better fit — or not — to take part right now?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Changes to patient management
Timeframe: 90 days post AMI
2
Time to diagnosis and/or treatment of cardiac arrhythmia